The device is intended for endovascular coagulation of blood vessels. The device is indicated for the endovascular coagulation of the greater saphenous vein in the thigh in patients with superficial vein reflux.

Device Description

The ELVeS kit with Radial Fibers contain the following components: (1) radial fiber; (2) access needle; (3) introducer sheath/ dilator; and (4) a guidewire.

AI/ML Overview

The provided text describes a 510(k) submission for the "Endo Laser Vein System Kit with Radial Fiber," and it focuses primarily on demonstrating substantial equivalence to predicate devices rather than presenting a performance study with acceptance criteria.

Therefore, I cannot provide a table of acceptance criteria and reported device performance from this document. The document states that "The device complies with the following voluntary consensus standards: 21 C.F.R. §§ 1040.10 & 1040.11; ANSI/AAMI ES1; IEC 601-1; IEC 601-2-22; EN 60825-1, and ANSI/AAMI/ISO 10993-7." However, it does not specify acceptance criteria derived from these standards, nor does it report device performance against specific metrics.

The document's central argument for substantial equivalence is based on:

The use of previously cleared radial fiber technology (K924258).
Having the same intended use and indications for use as cleared predicate devices (Ceralas D 1470, 980 and 810nm ELVeS kits).
The ELVeS kit not representing a new technological characteristic for diode lasers in endovascular coagulation of the greater saphenous vein.

Here's a breakdown of the other requested information based on the provided text:

A table of acceptance criteria and the reported device performance:
- Not provided in the document. The submission relies on substantial equivalence to predicate devices and compliance with general consensus standards, not on specific performance data against defined acceptance criteria.
Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective):
- Not applicable / Not provided. The document does not describe a performance study with a test set.
Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g., radiologist with 10 years of experience):
- Not applicable / Not provided. No performance study with a test set is described.
Adjudication method (e.g., 2+1, 3+1, none) for the test set:
- Not applicable / Not provided. No performance study with a test set is described.
If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
- No. This device is a laser system for endovascular coagulation, not an AI-assisted diagnostic or imaging device. Therefore, an MRMC study comparing human readers with and without AI assistance is not relevant or mentioned.
If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
- No. This is a medical device (laser system), not an algorithm. Standalone performance for an algorithm is not applicable.
The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
- Not applicable / Not provided. No performance study requiring ground truth is described.
The sample size for the training set:
- Not applicable / Not provided. This device is a laser system, not a machine learning algorithm requiring a training set.
How the ground truth for the training set was established:
- Not applicable / Not provided. As above, no training set for an algorithm is relevant here.

Summary

{0}------------------------------------------------

K101712

510(k) Summary Endo Laser Vein System Kit with Radial Fiber

Submitter's Name, Address, Telephone Number, Contact Person and Date Prepared

OCT 2 7 2010

Biolitec, Inc. 515 Shaker Road East Longmeadow, Massachusetts 01028 (413) 525-0600 Phone: Facsimile: (413) 525-0611

Contact Person: Harry Hayes, Ph.D. - Regulatory Consultant Date prepared: June 7, 2010

Name of Device and Name/Address of Sponsor

Endo Laser Vein System Kit (ELVeS®) with Radial Fiber Biolitec, Inc. 515 Shaker Road East Longmeadow, Massachusetts 01028

Classification Name

Surgical laser accessories

Predicate Devices

Ceralas D Diode Laser System (1470nm, 980 nm and 810 nm) with ELVeS Kit

Intended Use/Indication for Use

Technological Characteristics

The ELVeS kit with Radial Fibers contain the following components: (1) radial fiber; (2) access needle; (3) introducer sheath/ dilator; and (4) a guidewire.

Performance Data

The device complies with the following voluntary consensus standards: 21 C.F.R. §§ 1040.10 & 1040.11; ANSI/AAMI ES1; IEC 601-1; IEC 601-2-22; EN 60825-1, and ANSI/AAMI/ISO 10993-7.

{1}------------------------------------------------

Substantial Equivalence

The ELVes with Radial Fiber uses previously cleared radial fiber technology (K924258) and has the same intended use and indications for use as the cleared Ceralas D 1470, 980 and 810nm ELVeS kits. The ELVeS kit is not a new technological characteristic for diode lasers for endovascular coagulation of the greater saphenous vein in the thigh in patients with superficial vein reflux. Thus, the ELVeS is substantially equivalent to its predicate devices.

{2}------------------------------------------------

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services (HHS). The logo consists of a stylized image of an eagle or bird with outstretched wings, rendered in black lines. The bird is positioned to the right of a circular arrangement of text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". The text is also in black and is arranged to follow the curve of the circle.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Biolitec, Inc. % Genmarhay BDA Mr. Harry Hayes 1349 Main Road Granville, Massachusetts 01034

OCT 2 7 2010

Re: K101712

Trade/Device Name: Endo Laser Vein System Kit with Radial Fiber Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: Class II Product Code: GEX Dated: October 12, 2010 Received: October 13, 2010

Dear Mr. Hayes:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{3}------------------------------------------------

Page 2 - Mr. Harry Hayes

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

Sincerely yours.

Sincerely yours,

Mark N. Melkerson

Director Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{4}------------------------------------------------

Indications for Use Statement

510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________

OCT 2 7 2010

Device Name: Endo Laser Vein System Kit with Radial Fiber

For endovascular coagulation of the greater saphenous vein of the thigh in patients with superficial vein reflux.

(PLEASE DO NOT WRITE BELOW THIS LINE -- CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use _ V (Per 21 C.F.R. 801.109) OR

Over-The-Counter Use (Optional Format 1-2-96)

Neil K. Arlen for nxn
Division of Oil, Gas

(Division S. Division of Surgical, Orthopedic, and Restorative Devices

510(k) Number K101712

Regulation Number and Section

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.